Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending January 17, 2016
Adolescents and Young Adults With AML, How do their outcomes compare with their elders?
Osteonecrosis in Acute Lymphoblastic Leukemia, Assessing the safety of surgical intervention
A Paper-Based Test for Sickle Cell Anemia, Evaluating its sensitivity and specificity
Familial Hematologic Malignancies, Studying MDS/AML onset and lymphoid malignancies
BCR-ABL Transcripts in Chronic Myeloid Leukemia, Which have prognostic value?
Must reads for theWeek ending January 10, 2016
Hypomethylating Agents in Myelodysplastic Syndromes, Assessing response vs time of treatment
Routine Surveillance Imaging in Peripheral T-cell Lymphoma, Is it worthwhile?
Female Sex Hormones in Multiple Myeloma, Studying associations with risk
Polymorphic Variants in Lymphoid Tumors, Can they predict clinical outcome?
Irradiation After Spinal Cord Compression From Myeloma, Evaluating myeloma subtype as a prognostic factor
Must reads for theWeek ending December 27, 2015
Minimal Residual Disease in Acute Myeloid Leukemia, Should it be the basis for disease assessment?
Pregnancy in Hodgkin Lymphoma, Assessing risk of relapse
High-Risk Children With Sickle Cell Anemia, Comparing transfusions with hydroxycarbamide therapy
Fatigue With Myeloproliferative Neoplasms, Surveying patients on multiple factors
Lenalidomide and Dexamethasone in Myeloma, Evaluated vs melphalan-prednisone-thalidomide
Must reads for theWeek ending December 20, 2015
FDA Approves Vonvendi, Recombinant treatment for adults with von Willebrand disease
Carfilzomib Plus DXM in Relapsed or Refractory MM, Comparing it with bortezomib plus DXM
Preferences Among Hemophilia Patients, What is important to them?
FDA Approves Hair-Conserving Device, DigniCap may help patients with breast cancer during chemo
ACS/ASCO Joint Guideline on BC Survivor Care, An evidence-based guideline derived from literature review
Must reads for theWeek ending December 13, 2015
FDA Approves Generic Gleevec, Indicated for chronic myeloid leukemia
Panobinostat in Relapsed and Relapsed/Refractory Myeloma, Studied in combination with bortezomib and dexamethasone
RBC Storage Times in Pediatric Lactic Acidosis, Assessing reduction of elevated blood lactate levels
Ibrutinib in Chronic Lymphocytic Leukemia, Comparing it with chlorambucil
MRI Detection of Contralateral Breast Cancer, Assessing its long-term impact